GPCR GlobeNewswire 2 days ago Structure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights
GPCR Motley Fool 3 days ago Structure Therapeutics Stock Soars Over 200% as One Fund Adds to a $242 Million Position
GPCR Motley Fool 3 days ago Protagonist Stock Up 120%, but One Fund Just Revealed a $170 Million Exit ➖ AI Sentiment Neutral 4/10
GPCR Motley Fool 3 days ago Disc Medicine Stock Is Swinging, but This Fund's New $52 Million Bet Shows Conviction
GPCR Investor's Business Daily 6 days ago Novo Nordisk Dives As Next-Gen Obesity Drug Lags Eli Lilly's Kingpin 📉 AI Sentiment Negative 2/10